United States Precision Medicine Market Size, Growth and Report 2025-2033

United States Precision Medicine Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Growth Rate: 11.7% (2025-2033)

The United States precision medicine market is experiencing rapid growth, driven by advancements in genomics, personalized therapies, and increasing demand for targeted treatments to improve patient outcomes. According to the latest report by IMARC Group, The United States precision medicine market size reached USD 38.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 43.2 Billion by 2033, exhibiting a growth rate (CAGR) of 11.7% during 2025-2033.

United States Precision Medicine Industry Trends and Drivers:

Advancements in genomics and biotech are changing precision medicine in the United States. Personalized treatments fit individual genetic profiles. This improves patient outcomes and reduces side effects. The rise of chronic diseases, like cancer and diabetes, increases the need for targeted therapies. Government funding, such as NIH’s All of Us program, speeds up precision medicine development. Partnerships between drug companies and tech firms boost data-driven drug discovery. This cuts the time needed to bring new treatments to market. The growing use of electronic health records (EHRs) helps integrate genetic data into clinical decisions.

Another key driver is the rising patient awareness and demand for personalized healthcare. Companies like 23andMe provide direct-to-consumer genetic testing. This helps people understand their health risks and boosts preventive care. AI and machine learning analyze large datasets to find patterns. These patterns help create personalized treatment plans. Regulatory support, especially the FDA’s focus on biomarker-based drug approvals, encourages investment in precision medicine. The expansion of telemedicine improves access to specialized care, especially in rural areas. With healthcare costs rising, precision medicine offers cost-effective solutions by reducing trial-and-error treatments. These trends highlight the United States' role as a leader in advancing precision medicine worldwide.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-precision-medicine-market/requestsample

United States Precision Medicine Industry Segmentation:

The report has segmented the market into the following categories:

Analysis by Product:

• Consumables
• Instruments
• Services

Analysis by Technology:

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

Analysis by Application:

• Oncology
• Central Nervous System (CNS)
• Immunology
• Respiratory Medicine
• Infections
• Others

Analysis by End User:

• Hospitals and Clinics
• Diagnostic Centers
• Pharma and Biotech Companies
• Healthcare IT Firms
• Others

Regional Analysis:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145